Literature DB >> 14501786

Prospective analysis of HLA classes I and II antigen frequency in patients with Peyronie's disease.

Ekkehard W Hauck1, Arne Hauptmann, Wolfgang Weidner, Gregor Bein, Holger Hackstein.   

Abstract

PURPOSE: The pathogenesis of Peyronie's disease remains unclear. Previous studies have described possible associations among various HLAs and Peyronie's disease. However, only small series comprising 9 to 52 patients were analyzed in these studies and published results are controversial. We prospectively investigated a possible association of Peyronie's disease with HLA classes I and II specificity in a large patient group.
MATERIALS AND METHODS: A total of 154 consecutive patients with Peyronie's disease were typed serologically for HLA class I antigens. Molecular typing of HLA class II alleles was performed by polymerase chain reaction sequence specific primers. Results were compared with those in healthy bone marrow donors for HLA classes I (2,450) and II (316), serving as representative controls selected from the local population. In addition, HLA distribution in a German normal cohort of 14,835 individuals served as a control.
RESULTS: No significant difference in HLA classes I and II antigen frequency was evident in patients with Peyronie's disease compared with healthy controls.
CONCLUSIONS: The results of this study do not indicate any significant association between Peyronie's disease and antigens of the HLA system.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14501786     DOI: 10.1097/01.ju.0000076488.89748.e1

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  11 in total

1.  PEYRONIE'S DISEASE: A REVIEW OF ETIOLOGY, DIAGNOSIS, AND MANAGEMENT.

Authors:  Aylin N Bilgutay; Alexander W Pastuszak
Journal:  Curr Sex Health Rep       Date:  2015-06-01

Review 2.  Treatment of Peyronie's disease with PDE5 inhibitors: an antifibrotic strategy.

Authors:  Nestor F Gonzalez-Cadavid; Jacob Rajfer
Journal:  Nat Rev Urol       Date:  2010-03-09       Impact factor: 14.432

Review 3.  The Genetic Basis of Peyronie Disease: A Review.

Authors:  Amin S Herati; Alexander W Pastuszak
Journal:  Sex Med Rev       Date:  2016-01-08

4.  Significant familial clustering of Peyronie's disease in close and distant relatives.

Authors:  Kristina L Allen-Brady; Michael B Christensen; Ashlynn D Sandberg; Alexander W Pastuszak
Journal:  Andrology       Date:  2022-07-13       Impact factor: 4.456

5.  Intralesional hyaluronic acid: an innovative treatment for Peyronie's disease.

Authors:  Romano Gennaro; Davide Barletta; Gianni Paulis
Journal:  Int Urol Nephrol       Date:  2015-08-11       Impact factor: 2.370

6.  [Retroperitoneal fibrosis].

Authors:  S Burkhardt Soares; S Kukuk; A S Brandt; A Fehr; S Roth
Journal:  Urologe A       Date:  2008-04       Impact factor: 0.639

7.  ABO Blood Type and Risk of Peyronie's Disease in Japanese Males.

Authors:  Yozo Mitsui; Hideyuki Kobayashi; Fumito Yamabe; Koichi Nakajima; Koichi Nagao
Journal:  World J Mens Health       Date:  2022-01-01       Impact factor: 6.494

8.  Tunica albuginea allograft: a new model of LaPeyronie's disease with penile curvature and subtunical ossification.

Authors:  Ludovic Ferretti; Thomas M Fandel; Xuefeng Qiu; Haiyang Zhang; Hazem Orabi; Alex K Wu; Lia Banie; Guifang Wang; Guiting Lin; Ching-Shwun Lin; Tom F Lue
Journal:  Asian J Androl       Date:  2014 Jul-Aug       Impact factor: 3.285

Review 9.  Molecular Mechanisms and Current Pharmacotherapy of Peyronie's Disease: A Review.

Authors:  Fuxun Zhang; Feng Qin; Jiuhong Yuan
Journal:  Front Pharmacol       Date:  2021-05-20       Impact factor: 5.810

Review 10.  New discoveries in the basic science understanding of Peyronie's disease.

Authors:  Mark Jalkut; Nestor Gonzalez-Cadavid; Jacob Rajfer
Journal:  Curr Urol Rep       Date:  2004-12       Impact factor: 2.862

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.